Metabogenomics reveals four candidate regions involved in the pathophysiology of Equine Metabolic Syndrome.
Authors: L. Patterson Rosa, M. Mallicote, M. Long, S. Brooks
Journal: Molecular and cellular probes
Summary
# Editorial Summary: Metabogenomics and Equine Metabolic Syndrome Equine Metabolic Syndrome represents a complex disease state characterised by obesity, hyperinsulinaemia and peripheral insulin dysregulation, yet current diagnostic approaches are hampered by the dynamic nature of insulin homeostasis and labour-intensive assay procedures. Rosa and colleagues employed a novel metabogenomic strategy on 49 Arabian horses, utilising high-performance liquid chromatography/mass spectrometry (HPLC/MS) to identify 3,392 plasma metabolite features and correlate these with a composite EMS risk score derived from nine standard diagnostic variables. Genome-wide association analysis using the Affymetrix 670k SNP array identified four metabolite features significantly associated with EMS status and pinpointed four distinct genomic candidate regions harbouring 63 genes that collectively explained 43.52% of the variation in EMS phenotype. These four genomic loci illuminate previously uncharacterised pathways underlying genetic predisposition to EMS and suggest that specific plasma metabolites may serve as rapid, objective diagnostic biomarkers. For practitioners managing metabolic disease, these findings offer promise for developing faster, more accurate diagnostic tools that could refine our ability to identify at-risk horses earlier and tailor preventative nutritional and exercise interventions before clinical signs manifest.
Read the full abstract on PubMed
Practical Takeaways
- •Genetic testing based on these four candidate regions may eventually help identify horses predisposed to EMS before clinical signs develop, enabling earlier preventative management
- •Metabolomic biomarkers identified in this study could lead to faster, more accurate diagnostic tools than current insulin assays, improving the timeliness of EMS diagnosis and treatment
- •Understanding the genetic basis of EMS susceptibility may inform selective breeding decisions to reduce the prevalence of metabolic syndrome in at-risk populations like Arabians
Key Findings
- •Four metabolite features were significantly correlated with EMS score (P < 1.474 × 10-5) in 49 Arabian horses
- •Genome-wide association analysis identified four unique candidate genomic regions containing 63 genes associated with EMS-correlated metabolites (P = 6.787 × 10-7, Bonferroni)
- •Identified genomic markers capture 43.52% of the variation in EMS score phenotype, providing evidence for genetic predisposition to the condition
- •Metabogenomic approach using HPLC/MS identified 3392 high-confidence metabolite features from plasma, offering potential for improved diagnostic tools